Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 13;20(8):1834.
doi: 10.3390/ijms20081834.

B Cells and Antibodies in Kawasaki Disease

Affiliations
Review

B Cells and Antibodies in Kawasaki Disease

Michael E Lindquist et al. Int J Mol Sci. .

Abstract

The etiology of Kawasaki disease (KD), the leading cause of acquired heart disease in children, is currently unknown. Epidemiology supports a relationship of KD to an infectious disease. Several pathological mechanisms are being considered, including a superantigen response, direct invasion by an infectious etiology or an autoimmune phenomenon. Treating affected patients with intravenous immunoglobulin is effective at reducing the rates of coronary aneurysms. However, the role of B cells and antibodies in KD pathogenesis remains unclear. Murine models are not clear on the role for B cells and antibodies in pathogenesis. Studies on rare aneurysm specimens reveal plasma cell infiltrates. Antibodies generated from these aneurysmal plasma cell infiltrates showed cross-reaction to intracellular inclusions in the bronchial epithelium of a number of pathologic specimens from children with KD. These antibodies have not defined an etiology. Notably, a number of autoantibody responses have been reported in children with KD. Recent studies show acute B cell responses are similar in children with KD compared to children with infections, lending further support of an infectious disease cause of KD. Here, we will review and discuss the inconsistencies in the literature in relation to B cell responses, specific antibodies, and a potential role for humoral immunity in KD pathogenesis or diagnosis.

Keywords: B cells; aggresomes; antibodies; endothelial; inclusions; plasmablasts; virus-like particles.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Kawasaki T. Kawasaki disease. Acta Paediatr. 1995;84:713–715. doi: 10.1111/j.1651-2227.1995.tb13742.x. - DOI - PubMed
    1. Kuo H.C., Lo M.H., Hsieh K.S., Guo M.M., Huang Y.H. High-dose aspirin is associated with anemia and does not confer benefit to disease outcomes in Kawasaki disease. PLoS ONE. 2015;10:e0144603. doi: 10.1371/journal.pone.0144603. - DOI - PMC - PubMed
    1. Shingadia D., O’Gorman M., Rowley A.H., Shulman S.T. Surface and cytoplasmic immunoglobulin expression in circulating B-lymphocytes in acute Kawasaki disease. Pediatr. Res. 2001;50:538–543. doi: 10.1203/00006450-200110000-00019. - DOI - PubMed
    1. Chang C.J., Kuo H.C., Chang J.S., Lee J.K., Tsai F.J., Khor C.C., Chang L.C., Chen S.P., Ko T.M., Liu Y.M., et al. Replication and meta-analysis of GWAS identified susceptibility loci in Kawasaki disease confirm the importance of B lymphoid tyrosine kinase (BLK) in disease susceptibility. PLoS ONE. 2013;8:e72037. doi: 10.1371/journal.pone.0072037. - DOI - PMC - PubMed
    1. Lee H.H., Park I.H., Shin J.S., Kim D.S. Immunoglobulin V(H) chain gene analysis of peripheral blood IgM-producing B cells in patients with Kawasaki disease. Yonsei Med. J. 2009;50:493–504. doi: 10.3349/ymj.2009.50.4.493. - DOI - PMC - PubMed

MeSH terms